Class II

Drug Recall: Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.

Lannett Company Inc. · May 27, 2026

Reason for Recall

Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.

Distribution

Nationwide within the United States

States Affected

NATIONWIDE

Quantity Affected

3984 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0584-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.